» Articles » PMID: 25171860

MicroRNA-320a Inhibits Cell Proliferation, Migration and Invasion by Targeting BMI-1 in Nasopharyngeal Carcinoma

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2014 Aug 31
PMID 25171860
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

In the present study, we investigated the roles and molecular mechanisms of miR-320a in human nasopharyngeal carcinoma (NPC). miR-320a expression was strongly reduced in NPC tissues and cell lines. Overexpression of miR-320a significantly suppressed NPC cell growth, migration, invasion and tumor growth in a xenograft mouse model. A luciferase reporter assay revealed that miR-320a could directly bind to the 3' UTR of BMI-1. Overexpression of BMI-1 rescued miR-320a-mediated biological function. BMI-1 expression was found to be up-regulated and inversely correlated with miR-320a expression in NPC. Collectively, our data indicate that miR-320a plays a tumor suppressor role in the development and progression of NPC and may be a novel therapeutic target against NPC.

Citing Articles

Insights on Bmi-1 therapeutic targeting in head and neck cancers.

Reyes-Carmona J Oncol Res. 2025; 33(2):301-307.

PMID: 39866230 PMC: 11753991. DOI: 10.32604/or.2024.053764.


The Crucial Roles of Bmi-1 in Cancer: Implications in Pathogenesis, Metastasis, Drug Resistance, and Targeted Therapies.

Xu J, Li L, Shi P, Cui H, Yang L Int J Mol Sci. 2022; 23(15).

PMID: 35897796 PMC: 9367737. DOI: 10.3390/ijms23158231.


Extracellular vesicle-derived miR-320a targets ZC3H12B to inhibit tumorigenesis, invasion, and angiogenesis in ovarian cancer.

Huang Y, Xu M, Jing C, Wu X, Chen X, Zhang W Discov Oncol. 2022; 12(1):51.

PMID: 35201481 PMC: 8777536. DOI: 10.1007/s12672-021-00437-2.


MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy.

Liang Y, Li S, Tang L Biomedicines. 2021; 9(6).

PMID: 34071109 PMC: 8224659. DOI: 10.3390/biomedicines9060591.


Regulation of gene transcription of B lymphoma Mo-MLV insertion region 1 homolog (Review).

Zhou M, Xu Q, Huang D, Luo L Biomed Rep. 2021; 14(6):52.

PMID: 33884195 PMC: 8056379. DOI: 10.3892/br.2021.1428.